Biochemistry methods

Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay

Retrieved on: 
Wednesday, July 28, 2021
Natural sciences, Chemistry, Physical sciences, Laboratory techniques, Immunologic tests, Titration, Immunology, Biochemistry methods, Multiplex, Assay, Titer, Immunoassay

Bio-Techne, owner of the leading ProteinSimple branded protein analysis portfolio of products, and PROGEN will offer the Simple Plex AAV2 viral titer assay on Ella instruments, its multiplexing immunoassay system.

Key Points: 
  • Bio-Techne, owner of the leading ProteinSimple branded protein analysis portfolio of products, and PROGEN will offer the Simple Plex AAV2 viral titer assay on Ella instruments, its multiplexing immunoassay system.
  • Featuring antibodies from PROGEN, the Simple Plex AAV2 viral titer assay detects assembled viral capsids as well as the comprehensively characterized AAV2 standard to deliver industry leading specificity.
  • Available on the Ella platform, the Simple Plex AAV2 assay utilizes the recombinant AAV2 antibody (A20R) from industry leader PROGEN to quantify assembled AAV2 capsids.
  • "Working with ProteinSimple to develop the Simple Plex AAV2 assay was a great experience," said Katja Betts, CEO of PROGEN.

Curebase, InBios Announce Results of Virtual Clinical Trial of InBios COVID-19 Rapid Detection Test Using Curebase Platform

Retrieved on: 
Wednesday, July 14, 2021
Medicine, Natural sciences, Branches of biology, Immunologic tests, Medical tests, Medical terminology, Biochemistry methods, COVID-19 testing, Laboratory techniques, Immunoassay, COVID-19, Swab

For this study, Curebase converted drive-through COVID-19 testing centers in southern California into clinical research sites with its unique decentralized clinical trial software platform and virtual site support model.

Key Points: 
  • For this study, Curebase converted drive-through COVID-19 testing centers in southern California into clinical research sites with its unique decentralized clinical trial software platform and virtual site support model.
  • This process required no physical interaction with patients and enabled hundreds of people to be screened in a few weeks.
  • The SCoV-2 Ag Detect Rapid Test is a patent-pending lateral flow immunoassay intended for the qualitative detection of SARS-CoV-2 nucleoprotein antigen in direct nasal swab specimens.
  • The point-of-care test r equires no instrumentation or transport media step and can be performed on-site with results delivered in about 20 minutes.

Novel 4D-Metabolomics and 4D-Lipidomics Workflows, Libraries and ML-based CCS Prediction Tools to Transform Metabolomics and Lipidomics

Retrieved on: 
Monday, June 21, 2021
Science, Software, Other Science, Biotechnology, Research, Pharmaceutical, Health, Technology, Branches of biology, Natural sciences, Biology, Mass spectrometry, Biochemistry methods, Lipids, Omics, Systems biology, Lipidomics, Metabolomics, Bruker

Brukers collaborators are making major progress in 4D-Metabolomics by leveraging measured collision cross sections (CCS).

Key Points: 
  • Brukers collaborators are making major progress in 4D-Metabolomics by leveraging measured collision cross sections (CCS).
  • This allows CCS values to be utilized across the timsTOF community to increase confidence by reducing ambiguities - resulting in fewer false positive annotations.
  • Bruker also introduced CCS-Predict Pro, an optimized algorithm to predict CCS values across small molecule structures.
  • Dr. Lucy Woods, Bruker Business Unit Manager for Metabolomics & Lipidomics, commented: Our 4D-Lipidomics workflows utilizing CCS prediction with Kendrick Mass Defect analyses reduce ambiguity in lipid annotation.

Global Immunoassay Market (2021 to 2026) - Rising Incidence of Chronic and Infectious Diseases is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, May 10, 2021
Infectious diseases, Biotechnology, Health, Immunologic tests, Biochemistry methods, Immunoassay, Compound annual growth rate, ELISA, Academic disciplines

Reagents & kits account for the largest share of the immunoassay market and is expected to grow at the highest CAGR.

Key Points: 
  • Reagents & kits account for the largest share of the immunoassay market and is expected to grow at the highest CAGR.
  • ELISA accounted for the largest share of the immunoassay market in 2020.
  • Blood accounts for the largest share and is expected to grow at the highest CAGR of the immunoassay market.
  • Infectious diseases account for the largest share of the immunoassay market, owing to the surging prevalence of infectious diseases and the rising use of immunoassays in diagnostics and management.\n'

Agilex Biolabs and B2S Life Sciences on Immunoassay Bioanalysis for Clinical Trials

Retrieved on: 
Wednesday, April 28, 2021
Life sciences, Health sciences, Natural sciences, Analytical chemistry, Immunologic tests, Biochemistry methods, Bioanalysis, Pharmacokinetics, Toxicology, Immunoassay, Biopharmaceutical

Sales, Agilex Biolabs\' Director of Immunoassay, Ronald R. Bowsher PhD, Partner and Chief Scientific Officer at B2S Life Sciences, and Amy Rosen, Associate Director of Statistics at B2S.\nThe panel shared insights from many years working in immunoassay bioanalysis for clinical trials.

Key Points: 
  • Sales, Agilex Biolabs\' Director of Immunoassay, Ronald R. Bowsher PhD, Partner and Chief Scientific Officer at B2S Life Sciences, and Amy Rosen, Associate Director of Statistics at B2S.\nThe panel shared insights from many years working in immunoassay bioanalysis for clinical trials.
  • Ronald R. Bowsher said B2S has been working with Agilex Biolabs for more than four years, "Our relationship has evolved very well, and we understand each other\'s needs.
  • And despite the geographic differences, I think we\'ve had a very productive collaboration serving Agilex Biolabs\' customers," he said.\nDr Kurt J.
  • We offer services for both small molecules and biologics for PK, immunogenicity (PD) and biomarker bioanalysis utilising the two platforms of LC-MS/MS and Immunoassay.\n'

Immuno Oncology Assays Market worth $7.9 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, April 22, 2021
Natural sciences, Biology, Chemistry, Laboratory techniques, Biotechnology, Biochemistry methods, Immunologic tests, Assay, Titration, Monoclonal antibody, Polymerase chain reaction, Immunoassay

The consumables segment accounted for the largest share of the market in 2020.

Key Points: 
  • The consumables segment accounted for the largest share of the market in 2020.
  • Unlike instruments, consumables require repeat purchase, which results in their stable demand among end users.\nThe immuno-oncology assays market is segmented into PCR, immunoassay, NGS, flow cytometry, and ISH based on technology.
  • In 2020, the research applications segment accounted for the largest share of the market.
  • The emergence of cancer immunotherapy is driving this segments growth.\nThe immuno-oncology assays market is segmented into five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Immuno Oncology Assays Market worth $7.9 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, April 22, 2021
Natural sciences, Biology, Chemistry, Laboratory techniques, Biotechnology, Biochemistry methods, Immunologic tests, Assay, Titration, Monoclonal antibody, Polymerase chain reaction, Immunoassay

The consumables segment accounted for the largest share of the market in 2020.

Key Points: 
  • The consumables segment accounted for the largest share of the market in 2020.
  • Unlike instruments, consumables require repeat purchase, which results in their stable demand among end users.\nThe immuno-oncology assays market is segmented into PCR, immunoassay, NGS, flow cytometry, and ISH based on technology.
  • In 2020, the research applications segment accounted for the largest share of the market.
  • The emergence of cancer immunotherapy is driving this segments growth.\nThe immuno-oncology assays market is segmented into five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Worldwide Industry for Research Antibodies to 2025 - by Product, Clonality, Major Reactivities, Application, Host Species, End-user and Region

Retrieved on: 
Wednesday, April 14, 2021
Medical specialties, Branches of biology, Glycoproteins, Biology, Immunology, Immune system, Biochemistry methods, Antibodies, Primary and secondary antibodies, Recombinant antibodies, Monoclonal antibody

Research and market trends are also extrapolated by analyzing the funding, patent publications and sales trends of major players in the field.\nIn this report, the market for research antibodies is segmented based on product type, major reactivities, applications, and geography.

Key Points: 
  • Research and market trends are also extrapolated by analyzing the funding, patent publications and sales trends of major players in the field.\nIn this report, the market for research antibodies is segmented based on product type, major reactivities, applications, and geography.
  • Moreover, the advancement of biological discoveries will result inthe need for more molecular targets to be detected by their antibodies.
  • For example, even for the same protein molecule, antibodies for each of its many forms of post-translational modifications are needed.
  • This is likely to propel the growth of the research antibodies market during the forecast period.\nPrimary antibodies are used alone or in combination with a secondary antibody.

Global In-Vitro Diagnostic Reagents (Antibodies, Oligonucleotide, Nucleic Acid Probe) Markets, 2020-2027

Retrieved on: 
Wednesday, April 14, 2021
Immunologic tests, Biochemistry methods, Immunoassay

The study also evaluates industry competitors and analyzes the market at regional level.\nBased on technology, the immunoassay/immunochemistry segment is estimated to dominate the overall IVD reagents market in 2020.

Key Points: 
  • The study also evaluates industry competitors and analyzes the market at regional level.\nBased on technology, the immunoassay/immunochemistry segment is estimated to dominate the overall IVD reagents market in 2020.
  • The large share of this segment is mainly attributed to the increasing use of immunoassays in infectious disease testing, development of novel tests, and rising demand for immunoassay-based tests.
  • However, the oligonucleotides segment is expected to grow at the fastest CAGR during the forecast period.
  • However, the clinical laboratories segment is expected to register the highest growth during the forecast period, due to the rising number of accredited clinical laboratories; growing collaborations, partnerships, and other strategies undertaken by the key players; and outbreak of COVID-19.\n'

Hardy Diagnostics Releases New Mass Spectrometer for Use in Non-Clinical Applications

Retrieved on: 
Friday, April 2, 2021
Mass spectrometry, Biochemistry methods, Ion source, Matrix-assisted laser desorption/ionization, Hardy Diagnostics, Time-of-flight mass spectrometry

SANTA MARIA, Calif., April 2, 2021 /PRNewswire/ --Hardy Diagnostics, in collaboration with Autobio, recently launched the Hardy Diagnostics Matrix-Assisted Laser Desorption/Ionized Time of Flight instrument, otherwise known as

Key Points: 
  • SANTA MARIA, Calif., April 2, 2021 /PRNewswire/ --Hardy Diagnostics, in collaboration with Autobio, recently launched the Hardy Diagnostics Matrix-Assisted Laser Desorption/Ionized Time of Flight instrument, otherwise known as
    MALDI-TOF .
  • This launch is an example of the diversification of Hardy Diagnostics' product portfolio and further development of instrumentation for use in microbiology labs.
  • Jay Hardy, Hardy Diagnostics Chief Executive Officer stated, "We are very excited to add the MALDI Autof MS 1000 to our lineup of instruments to streamline the processes for microbiologists."
  • Hardy Diagnostics has previously introduced automated Gram stain and automated Hematology stain instruments , as well as air sampling , automated serial dilution , and automated plate reading instrumentation .